Current pharmacological management of amyotropic lateral sclerosis and a role for rational polypharmacy

Author： Weiss Michael D   Weydt Patrick   Carter Gregory T  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.5, Iss.4, 2004-04, pp. : 735-746

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting angiogenin in therapy of amyotropic lateral sclerosis

By Kishikawa Hiroko   Wu David   Hu Guo-fu  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 10, 2008-10 ,pp. : 1229-1242

Informa Healthcare

Access to resources Recommend Favorite

Emerging disease-modifying therapies for the treatment of motor neuron disease/amyotropic lateral sclerosis

By Bedlack Richard S   Traynor Bryan J   Cudkowicz Merit E  

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 2, 2007-05 ,pp. : 229-252

Informa Healthcare

Access to resources Recommend Favorite

A strategy for developing effective amyotropic lateral sclerosis pharmacotherapy: from clinical trials to novel pharmacotherapeutic strategies

By Yamamoto Masahiko   Tanaka Fumiaki   Tatsumi Hiroshi   Sobue Gen  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 11, 2008-08 ,pp. : 1845-1857

Informa Healthcare

Access to resources Recommend Favorite

Management of Amyotrophic Lateral Sclerosis

By Corcia Philippe   Meininger Vincent  

Drugs, Vol. 68, Iss. 8, 2008-01 ,pp. : 1037-1048

Adis International

Access to resources Recommend Favorite

The Role of Creatine in the Management of Amyotrophic Lateral Sclerosis and Other Neurodegenerative Disorders

By Amy Cameron Ellis   Jeffrey Rosenfeld  

CNS Drugs, Vol. 18, Iss. 14, 2004-01 ,pp. : 967-980

Adis International

Access to resources Recommend Favorite